Author

Y. Konno

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Maruyama· 1 shared H. Makinoshima· 1 shared I. Kimura· 1 shared J. Nakayama· 1 shared K. Sato· 1 shared K. Uriu· 1 shared M. Fukushi· 1 shared M. Tomita· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Maruyama

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cinnamon bark extract suppresses metastatic dissemination of cancer cells through inhibition of glycolytic metabolism

Y. Konno, A. Maruyama, M. Tomita, H. Makinoshima, J. Nakayama

Cinnamon bark extract suppresses cancer cell metastasis by inhibiting glycolytic metabolism, as shown through zebrafish models and metabolomic analysis.

bioRxiv · Mar 25, 2021Pharmacology & Toxicology

SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant

Y. Konno, I. Kimura, K. Uriu, M. Fukushi, T. Irie, Y. Koyanagi, S. Nakagawa, K. Sato

This paper shows that SARS-CoV-2 ORF3b is a potent interferon antagonist, with a naturally occurring longer variant enhancing its anti-interferon activity in severe COVID-19 cases.

bioRxiv · May 11, 2020Microbiology